Evidence map›Paper›PMID 34833379›Full record

ArticleMedicina (Kaunas, Lithuania)2021

Oxygen: A Stimulus, Not "Only" a Drug.

Costantino Balestra, Jacek Kot

Registry-linked trialOpen access · goldAbstract readEditorial
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07551869 (Oxygen as a Metabolic Modulator), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07551869 nacompletednot on this mapstarted 2023, after this paper: background citation

Oxygen as a Metabolic Modulator: Divergent Physiological Adaptations to Hypoxic and Hyperoxic Tabata Training.

TypeinterventionalSponsorHaute Ecole Bruxelles-BrabantRan2023 to 2025Enrolled23ConditionsHyperoxia / High FiO₂ Exposure, Interval Training, HIIT, High Intensity Interval TrainingArmsFIO2 modulation during HIIT protocol on assault bike
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Costantino BalestraLaboratory of Environmental and Occupational (Integrative) Physiology, Haute Ecole Bruxelles-Brabant, Auderghem, 1160 Brussels, Belgium.ORCID 0000-0001-6771-839X
Jacek KotNational Center of Hyperbaric Medicine in Gdynia, Medical University of Gdansk, 80-210 Gdansk, Poland.ORCID 0000-0001-5604-8407
Gdańsk Medical University · PLHaute École de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Depending on the oxygen partial pressure in a tissue, the therapeutic effect of oxygenation can vary from simple substance substitution up to hyperbaric oxygenation when breathing hyperbaric oxygen at 2.5-3.0 ATA. Surprisingly, new data showed that it is not only the oxygen supply that matters as even a minimal increase in the partial pressure of oxygen is efficient in triggering cellular reactions by eliciting the production of hypoxia-inducible factors and heat-shock proteins. Moreover, it was shown that extreme environments could also interact with the genome; in fact, epigenetics appears to play a major role in extreme environments and exercise, especially when changes in oxygen partial pressure are involved. Hyperbaric oxygen therapy is, essentially, "intermittent oxygen" exposure. We must investigate hyperbaric oxygen with a new paradigm of treating oxygen as a potent stimulus of the molecular network of reactions.

Indexed as

Hyperbaric OxygenationPharmaceutical PreparationsHumansOxygenOxygenPharmaceutical Preparationsepigeneticshyperbaric oxygenhyperoxic-hypoxic paradoxnormobaric oxygen paradoxoxygen

Identifiers

PMID34833379
PMCPMC8623056
OpenAlexW3210020590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.